OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients
Kaiyan Liu, Sydney Stern, Emily L. Heil, et al.
Hepatology Communications (2023) Vol. 7, Iss. 3, pp. e0034-e0034
Open Access | Times Cited: 9
Kaiyan Liu, Sydney Stern, Emily L. Heil, et al.
Hepatology Communications (2023) Vol. 7, Iss. 3, pp. e0034-e0034
Open Access | Times Cited: 9
Showing 9 citing articles:
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Intranasal liposomal remdesivir induces SARS-CoV-2 clearance in K18-hACE2 mice and ensures survival
Sabrina Mendes, Lays Cordeiro Guimarães, Leonardo Camilo de Oliveira, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 558-573
Closed Access
Sabrina Mendes, Lays Cordeiro Guimarães, Leonardo Camilo de Oliveira, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 558-573
Closed Access
Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature
Harjit Singh, Bryce Kunkle, Angela Troia, et al.
Drug Safety (2025)
Closed Access
Harjit Singh, Bryce Kunkle, Angela Troia, et al.
Drug Safety (2025)
Closed Access
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges
Daniele Focosi, David J. Sullivan, Massimo Franchini
Expert Review of Anti-infective Therapy (2025)
Closed Access
Daniele Focosi, David J. Sullivan, Massimo Franchini
Expert Review of Anti-infective Therapy (2025)
Closed Access
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
Alireza FakhriRavari, Mazyar Malakouti
(2024)
Open Access | Times Cited: 1
Alireza FakhriRavari, Mazyar Malakouti
(2024)
Open Access | Times Cited: 1
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
Alireza FakhriRavari, Mazyar Malakouti
Pharmacoepidemiology (2024) Vol. 3, Iss. 1, pp. 69-81
Open Access | Times Cited: 1
Alireza FakhriRavari, Mazyar Malakouti
Pharmacoepidemiology (2024) Vol. 3, Iss. 1, pp. 69-81
Open Access | Times Cited: 1
Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID‐19
Tsuyoshi Jinda, Shinsuke Mizuno, Shunsuke Tatami, et al.
Journal of Paediatrics and Child Health (2024) Vol. 60, Iss. 7, pp. 299-302
Open Access | Times Cited: 1
Tsuyoshi Jinda, Shinsuke Mizuno, Shunsuke Tatami, et al.
Journal of Paediatrics and Child Health (2024) Vol. 60, Iss. 7, pp. 299-302
Open Access | Times Cited: 1
Mechanistic understanding of dexamethasone-mediated protectionagainst remdesivir-induced hepatotoxicity
Kaiyan Liu, Zhihui Li, Linhao Li, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 71-82
Open Access
Kaiyan Liu, Zhihui Li, Linhao Li, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 71-82
Open Access
Human Hepatic Spheroid Coculture Model for the Assessment of Drug-Induced Liver Injury
Linhao Li, Hongbing Wang
Methods in molecular biology (2023), pp. 85-90
Closed Access
Linhao Li, Hongbing Wang
Methods in molecular biology (2023), pp. 85-90
Closed Access
